AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Mateq Ali Alreshidi الدكتور/ معتق بن علي الرشيدي

Mateq Ali Alreshidi الدكتور/ معتق بن علي الرشيدي i

Sulaiman Al Rajhi University - Al Bukayriyah / Saudi Arabia
Medical and Health Sciences / Medical Microbiology
AD Scientific Index ID: 466151
-
person_outline Mateq Ali Alreshidi الدكتور/ معتق بن علي الرشيدي's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK The Lancet 397 (10269), 99-111, 2021
2-) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial The Lancet 396 (10249), 467-478, 2020
3-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Lancet (London, England) 397 (10285), 1637, 2021
4-) Synthesis, characterization, applications, and challenges of iron oxide nanoparticles Nanotechnology, science and applications, 49-67, 2016
5-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial The Lancet 396 (10267), 1979-1993, 2020